Brief: Medrx commences phase I clinical trial for spastic paralysis treatment plasters in U.S.
Oct 7 (Reuters) - Medrx Co Ltd 4586.T :
* Says it commenced the phase I clinical trial for spastic
paralysis treatment plasters(MRX-4TZT) in the U.S.
Source text in Japanese:https://goo.gl/N7uk4m
Further company coverage: 4586.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))